Cardiome Pharma Corp. (CRME) Misses Q3 EPS by 11c

Cardiome Pharma Corp. (NASDAQ: CRME) reported Q3 EPS of ($0.22), $0.11 worse than the analyst estimate of ($0.11). Revenue for the quarter came in at $100 thousand.

For earnings history and earnings-related data on Cardiome Pharma Corp. (CRME) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Optimum Communications gets NYSE non-compliance notice over stock price
• Zeo Energy Corp (ZEO) Misses Q2 EPS by 7c